MONTREAL, Oct. 8, 2013 /CNW Telbec/ - PROCURE and the Cancer Research
Society today jointly announced the PROCURE Biobank/Cancer Research Society Partnership to fund a biobank specializing in prostate cancer. This partnership,
which represents a new investment of $4.5 million over five years, will
provide additional support for prostate cancer research initiatives.
In Canada, it is estimated that one in seven men will develop prostate
cancer over their lifetime and that one in 27 will die of it. In 2013,
about 23,600 Canadian men, including 4,800 in Quebec, will be diagnosed
with prostate cancer1.
"The financial support announced today will allow us to achieve greater
impact: we will provide researchers in the Canadian and international
scientific communities with biological samples and data for innovative,
large-scale projects against prostate cancer," said Cédric Bisson,
Chairman of the Board of PROCURE.
"The PROCURE Biobank/Cancer Research Society Partnership is an important contribution to scientific advancement," added Andy Chabot,
President and CEO, Cancer Research Society. "This partnership
underscores our mission to fund research on all types of cancer."
The Partnership is also generously funded by three local family foundations. The Mirella & Lino Saputo Foundation, the Lemaire Family Foundation and the Antonopoulos Group are all contributing to the efforts to conquer prostate cancer.
"We're proud to be part of the Partnership and to support the biobank, which aims to accelerate research that will
identify key elements in prostate cancer, as well as prevent and cure
it," said Alain Lemaire, Executive Chairman of the Board of Cascades.
"We had no doubt that we had to take part in this project, which
highlights the expertise of Quebec's scientific researchers and,
hopefully, will find a cure for this disease," added Lino Saputo,
Chairman of the Board of Saputo Inc.
"This is an inspiring and innovative project. For our family, it was
only natural to get involved and contribute to scientific advances that
will make it possible to put an end to this form of cancer," concluded
Costa Antonopoulos, Co-founder of the Antonopoulos Group.
Founded in 2003, PROCURE's mission is to provide science and humanity
with the means to help prevent and cure prostate cancer. It is the only
charitable organization in Quebec to be devoted entirely to the fight
against this form of cancer. The biobank, which PROCURE created in 2007
in collaboration with the four Quebec University-based hospital systems
(CHUM, CHUS, CHUQ and MUHC), is aimed at accelerating breakthroughs in
prostate cancer research. PROCURE also offers the public and healthcare
professionals a comprehensive bilingual website (www.procure.ca) with regularly updated information. PROCURE also contributes to
supporting patients and their caregivers, providing the services of a
urology nurse upon request.
About the Cancer Research Society
Founded in 1945, the Cancer Research Society is a national
not-for-profit organization whose sole mission is to fund research on
all types of cancer, thereby contributing to the advancement of science
aimed at preventing, detecting, and treating this disease. Over the
past 20 years, the CRS has allocated $113 million to nearly 900 cancer
research projects across the country, including $41 million in the past
five years. The Society is already very active in funding prostate
cancerprojects, which currently represent 22% of its total
1Advisory Council on Research, Canadian Cancer Society: Canadian Cancer Statistics, 2013
SOURCE: Cancer Research Society
For further information:
514-341-3000, ext. 2
Cancer Research Society
514-861-9227, ext. 248
Morin Relations Publiques
514-289-8688, ext. 234